Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion type Assertion NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_head.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion description "[Thiazolidinediones/PPAR? agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_provenance.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion evidence source_evidence_literature NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_provenance.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion SIO_000772 21170507 NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_provenance.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion wasDerivedFrom befree-2016 NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_provenance.
- NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_assertion wasGeneratedBy ECO_0000203 NP860361.RAGrto0E2cBdkYndzVNNgfUqJTlqtOS5_A5sjKaQSN3yg130_provenance.